To date, HOXB7 has been implicated to be aberrantly expressed in several types of cancers, including breast cancer (53), gliomas (54), gastric cancer (55), esophageal squamous cell carcinoma (56), intrahepatic cholangiocarcinoma (57), and cervical cancer (58). Here, HOXB7 is linked to glioma.